200 related articles for article (PubMed ID: 35122005)
21. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.
Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T
Front Immunol; 2020; 11():1559. PubMed ID: 32849529
[TBL] [Abstract][Full Text] [Related]
22. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer.
Wang Y; Ren F; Wang Y; Feng Y; Wang D; Jia B; Qiu Y; Wang S; Yu J; Sung JJ; Xu J; Zeps N; Chang Z
Carcinogenesis; 2014 May; 35(5):983-91. PubMed ID: 24302614
[TBL] [Abstract][Full Text] [Related]
23. ABLIM1, a novel ubiquitin E3 ligase, promotes growth and metastasis of colorectal cancer through targeting IĸBα ubiquitination and activating NF-ĸB signaling.
He Y; Shi Q; Ling Y; Guo H; Fei Y; Wu R; Tang C; Zhang X; Yao L
Cell Death Differ; 2024 Feb; 31(2):203-216. PubMed ID: 38228802
[TBL] [Abstract][Full Text] [Related]
24. RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation.
Tian Y; Zhang Y; Zhong B; Wang YY; Diao FC; Wang RP; Zhang M; Chen DY; Zhai ZH; Shu HB
J Biol Chem; 2007 Jun; 282(23):16776-82. PubMed ID: 17449468
[TBL] [Abstract][Full Text] [Related]
25. Metastasis suppressor 1 acts as a tumor suppressor by inhibiting epithelial-to-mesenchymal transition in triple-negative breast cancer.
Yu J; Shen W; Gao B; Xu J; Gong B
Int J Biol Markers; 2020 Mar; 35(1):74-81. PubMed ID: 32052679
[TBL] [Abstract][Full Text] [Related]
26. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
[TBL] [Abstract][Full Text] [Related]
27. Developmental expression and differentiation-related neuron-specific splicing of metastasis suppressor 1 (Mtss1) in normal and transformed cerebellar cells.
Glassmann A; Molly S; Surchev L; Nazwar TA; Holst M; Hartmann W; Baader SL; Oberdick J; Pietsch T; Schilling K
BMC Dev Biol; 2007 Oct; 7():111. PubMed ID: 17925019
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer.
Wu W; Wang Z; Yang P; Yang J; Liang J; Chen Y; Wang H; Wei G; Ye S; Zhou Y
Mol Cell Biochem; 2014 Mar; 388(1-2):249-59. PubMed ID: 24343340
[TBL] [Abstract][Full Text] [Related]
29. Inhibitor of growth 4 induces NFκB/p65 ubiquitin-dependent degradation.
Hou Y; Zhang Z; Xu Q; Wang H; Xu Y; Chen K
Oncogene; 2014 Apr; 33(15):1997-2003. PubMed ID: 23624912
[TBL] [Abstract][Full Text] [Related]
30. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
31. Metastasis suppressor 1 (MTSS1) expression is associated with reduced in-vivo metastasis and enhanced patient survival in lung adenocarcinoma.
Taylor MD; Bollt O; Iyer SC; Robertson GP
Clin Exp Metastasis; 2018 Feb; 35(1-2):15-23. PubMed ID: 29218652
[TBL] [Abstract][Full Text] [Related]
32. Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis.
Agarwal E; Robb CM; Smith LM; Brattain MG; Wang J; Black JD; Chowdhury S
Oncogene; 2017 Jun; 36(22):3104-3118. PubMed ID: 28068324
[TBL] [Abstract][Full Text] [Related]
33. Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma.
Huang XY; Huang ZL; Xu B; Chen Z; Re TJ; Zheng Q; Tang ZY; Huang XY
J Exp Clin Cancer Res; 2016 May; 35(1):85. PubMed ID: 27230279
[TBL] [Abstract][Full Text] [Related]
34. MTSS1 suppresses cell migration and invasion by targeting CTTN in glioblastoma.
Zhang S; Qi Q
J Neurooncol; 2015 Feb; 121(3):425-31. PubMed ID: 25385572
[TBL] [Abstract][Full Text] [Related]
35. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
[TBL] [Abstract][Full Text] [Related]
36. Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen.
Donley C; McClelland K; McKeen HD; Nelson L; Yakkundi A; Jithesh PV; Burrows J; McClements L; Valentine A; Prise KM; McCarthy HO; Robson T
Oncogene; 2014 Jun; 33(26):3441-50. PubMed ID: 23912458
[TBL] [Abstract][Full Text] [Related]
37. Circ_002059 suppresses cell proliferation and migration of gastric cancer via miR-182/MTSS1 axis.
Li T; Zuo X; Meng X
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):454-462. PubMed ID: 33686422
[TBL] [Abstract][Full Text] [Related]
38. EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail.
Yang J; Liao Y; Wang B; Cui L; Yu X; Wu F; Zhang Y; Liu R; Yao Y
Cancer Lett; 2023 Nov; 577():216427. PubMed ID: 37838280
[TBL] [Abstract][Full Text] [Related]
39. MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer.
Vadakekolathu J; Al-Juboori SIK; Johnson C; Schneider A; Buczek ME; Di Biase A; Pockley AG; Ball GR; Powe DG; Regad T
Cell Death Dis; 2018 Mar; 9(3):344. PubMed ID: 29497041
[TBL] [Abstract][Full Text] [Related]
40. Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.
Du P; Ye L; Ruge F; Yang Y; Jiang WG
Anticancer Res; 2011 Oct; 31(10):3205-12. PubMed ID: 21965727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
